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Abstract: Celiac disease may present with a range of different symptoms, including abdominal
problems in a broader sense, iron deficiency and “constant tiredness”. All of these symptoms should
consequently lead the clinicians to consider celiac disease as a potential etiopathogenetic cause.
Although the pathophysiology of celiac disease is well documented, the actual mechanisms for
disease presentation(s) are less well understood. We here address the topic of fatigue in celiac disease.
A systematic literature search identified 298 papers of which five met the criteria for full evaluation.
None of the reviewed papers were of high quality and had several methodological weaknesses.
We conclude that there is an unmet need to study the contributing factors and management of fatigue
in celiac disease.
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1. Introduction
Celiac disease is by definition an inflammatory disorder in the small intestine that is driven by
dietary gluten from wheat, rye and barley [1]. The disease is often also termed an autoimmune disease
due to a hallmark of the disease; autoantibodies to the endogenous enzyme tissue transglutaminase
TG2. The crucial importance of intestinal inflammation and the most frequent presentation of the
disease as a severe malabsorption syndrome led most clinicians to think of the disease as mainly an
intestinal disorder. However, we now know that a very large proportion of the patients do not primarily
display intestinal complaints, but that their disease presentation is more coloured by extra-intestinal
manifestations [2,3]. In a recent review by Leffler et al. [3] this is well described, including anaemia,
musculoskeletal, skin, neurological and organ-specific manifestations. Some of these manifestations
are caused by the intestinal disorder, others may be caused by systemic inflammation and/or genetic
overlap to other immune disorders [4]. Today we consider that symptoms like abdominal problems in
the wider sense, unexplained iron deficiency and “constant tiredness” should all prompt the clinicians
to consider celiac disease [5,6].
From our own clinical practice, we experience many patients with untreated celiac disease that
suffer from fatigue. In most cases fatigue improves with diet, but far from always. In addition,
these patients also present with a significant reduction in their health-related quality of life [2]. Fatigue
is described as a “persistent, overwhelming sense of tiredness, weakness or exhaustion resulting in a
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decreased capacity for physical and/or mental work”. While fatigue may be a natural and transient
part of life, a typical feature in chronic disease is that these symptoms are unrelieved by adequate
sleep or rest [7]. The aetiopathogenesis of fatigue in chronic disease appears to result from a complex
inter-relationship of biological, psychosocial and behavioural processes [8].
The aim of this review was consequently to address the aspect of fatigue in celiac disease and to
systematically summarise the existing literature on this topic.
2. Materials and Methods
Multiple searches were undertaken using MEDLINE, CINAHL, EMBASE, Psychinfo, Academic
Search Premiere, and Cochrane. Both medical subject heading (MeSH) searching and free-text searching
were used to maximize citation retrieval (Table 1). The searches were performed independently by a
university librarian, and one of the co-authors (L.-P.J.-J.).
Table 1. Search terms used for literature search.
Fatigue Coeliac Disease
Fatigue (MeSH) Coeliac disease
Mental fatigue
Chronic fatigue
Tiredness
Exhaustion
Weariness
Vitality
Asthenia
Low energy
Due to the limited number of publications on fatigue in coeliac disease, no time limit was set for
the papers. The searches were performed between April and June 2018, and the most recent search
was performed on August 5th, 2018. The searches were limited to “humans”, “adult” and English
language since there was no scope for translation.
Studies with all types of designs were included if they had measured and reported data on fatigue
in patients with celiac disease. Reviews, commentaries, abstracts/posters, case reports, protocols and
letters to editors were excluded. The review was conducted in line with the PRISMA guidelines [9].
3. Results
The search yielded 298 references in total, of which 248 were excluded on title (Figure 1).
After removing duplicates and screening the remaining 42 papers, a total of 16 papers were examined
in full. Of these 16 papers, 11 did not report any specific methodology for fatigue measurement and
were consequently excluded. Hence, a total of five papers were included in full review. Figure 1
describes the citation retrieval and the handling process in detail.
3.1. Quality Assessment
The quality of the included papers was assessed using the Joanna Briggs Institute Critical
Appraisal Checklist, specific to the methodological design of each paper. The studies were classified
as being of high, medium or low quality. A quality score was reduced if the paper did not define
fatigue, report the sample size, if the sample size was judged inadequate according to study design,
if the response rate was low or not reported, if the questionnaires used were not validated, if the
methods and statistical analysis was insufficiently described or if there were indications of selective
reporting. Two researchers (T.B./L.-P.J.-J.) performed quality assessment independently to ensure
optimal assessment of the included papers. Based on these criteria, all of the reviewed papers had
several methodological weaknesses, and none were judged to be of high quality. However, due to
the low number of publications on fatigue and celiac disease, none of the papers were excluded from
full-review based on quality.
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3.2. Outline of the Included Papers
In total, three papers assessed fatigue as the primary endpoint, one study investigated
extra-intestinal symptoms and health-related quality of life (HRQoL), while one study assessed
quality of sleep. An overview of the included papers is presented in Table 2.
Table 2. Summary of the includ d articles.
Study
(Ref. No.)
Study
Population and Setting
Study Design
and
Participants
Questionnaires
Measuring
Fatigue
Strengths and Limitations
Häuser et al.,
2006 [10]
A subgroup of m mbers
(1000/18,355) from the German
Coeliac Society (GZG) ≥18 years was
invited to participate
Every 18th person on the membership
list was invited in order to ensure a
geographically representative sample
Normative data were collected from
the handbooks of the SF-36, GBB-24
and HADS-D
Exclusion criteria: <18 years of age
Cross-sectional
design
Available for
analyses:
n = 446
SF-36 (Vitality
subscale)
GBB-24 (Fatigue
subscale)
L: Fatigue not specified as aim,
merely reported as parts of the
questionnaire results
L: No definition of fatigue
L: Sample consisting of members of a
atient society only
L: Low response rate
S: Normative data for comparison
L: Self-reported information on
comorbidity
L: Single centre study
S: Validated instruments used
L: Coeliac disease diagnosis
self-reported only
Siniscalchi
et al., 2005 [11]
Caucation adults ≥18 years of age
from Campania, Italy, were
consecutively recruited from an
outpatient clinic
Participants divided into two groups
(Group 1: Patients on gluten
cont ining diet, Group 2: Patients on
gluten-free diet)
Control group consisted of volunteers
recruited from medical an
non-medical hospital staff
Exclusion criteria: <18 years of age,
lack of informed consent, major
psychiatric disease, active thyroid
gland di ease
Cross-sectional
design
Coeliac disease:
n = 130
Control group:
n = 80
CFS
FSS
VAS
S: Definition of fatigue.
L: Inadequate language
L: Groups not comparable due to
differences in BMI, Ferritin,
Haemoglobin
L: No evidence of appropriate
matching of groups
L: Inadequate statistical control for
differences between groups
L: Methods used to collect
socio-demographic and clinical data
is lacking
L: Unclear presentation of results
L: Procedure for questionnaire
handling insufficiently describ d
L: Lack of information about validity
and reliability on the study
questionnaires, both in Italian and in
the target group
L: No clear identification and control
of potential confounding factors
L: Data not presented in line with
study aims
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Table 2. Cont.
Study
(Ref. No.)
Study
Population and Setting
Study Design
and
Participants
Questionnaires
Measuring
Fatigue
Strengths and Limitations
Jordá et al.,
2010 [12]
Patients with celiac disease seen
between March 2008 and April 2009
were prospectively invited to
participate in the study
Included patients stratified in two
groups (Group 1: Following
gluten-free diet, Group 2: Untreated)
Cross-sectional
study
n = 51
Group 1: n = 38
Group 2: n = 13
D-FIS
L: No definition of fatigue.
S: Validated fatigue questionnaire used
L: Small sample and small subgroups
L: Lack of information on
recruitment procedure
L: Lack of information concerning the
collection of socio-demographic and
clinical data
L: No information on ethical approval
L: No information about response rate or
number of patients approached
for inclusion
L: Characteristics differ between groups
Ciacci et al.,
2007 [13]
Patients with CD screened for
inclusion at the Department of
Clinical and Experimental Medicine,
Federico II University—Naples, Italy6
0 patients randomized following a
30-day gluten-free diet
Randomized,
double blind,
parallel study
n = 60
(L-Carnitine
group n = 30,
placebo n = 30)
Scott-Huskisson
VAS
VSA
SF-36 (Vitality
subscale)
S: Definition of fatigue
S: Randomized groups
S: Allocation concealment
S: Clear definition of coeliac disease
L: Large number of participants did not
complete study (n = 13 (22%))
L: Single centre
L: Lack of calculation of effect size
L: No information on validity/reliability
of fatigue questionnaires
Zingone
et al., 2010
[14]
Adult coeliac disease patients
consecutively recruited from
September 2009 to March 2010 from
Frederico II University (Naples, Italy)
Participants divided into two groups
(Group 1: Coeliac patients at
diagnosis on gluten containing diet.
Group 2: Coeliac patients at follow up
on gluten-free diet)
Gender- and age-matched
control group
Inclusion criteria: Informed consent,
19–60 years
Exclusion criteria: Major psychiatric
disease, cancer, pregnancy or children
blow 3 years of age
Case Control
study
Group 1: n = 30
Group 2: n = 30
Control group:
n = 30
Fatigue-VAS
L: Fatigue not specified as aim, merely
reported as parts of the
questionnaire results.
L: No definition of fatigue
L: No information about response rate or
number of patients approached
for inclusion
L: Large numeric differences in
characteristics between coeliac groups
L: No control for confounding variables
S: Gender- and age-matched controls
Table legends and abbreviations: L; Limitation., S; Strength., SF-36; Short Form-36 Health Survey., D-FIS;
Daily Fatigue Impact Scale., FSS; Fatigue Severity Scale., CFS; Chronic Fatigue Syndrome Questionnaire., GBB-24.,
Geißener Symptom Check List., VSA; Verbal Scale for Asthenia, VSA. CD; Coeliac disease, HADS-D; Hospital
anxiety and depression scale – depression.
3.3. Definition and Measurement of Fatigue
In two out of five papers, a definition or a more detailed description of fatigue was provided.
Both Siniscalchi et al. [11] and Ciacci et al. [13] defined fatigue as ”difficulty in initiating or sustaining
regular activities”. However, in none of these studies a reference to the definition were provided.
In total, six different ways of measuring fatigue have been used in the five studies reviewed.
Five of these instruments have only been used once. In addition, one study has used the sub-scale
vitality from the health-related quality of life questionnaire SF-36.
In a majority of the papers, there is lack of information about the validity and reliability of the
instruments used to measure fatigue. While Häuser et al. [10] and Jordá et al. [12] provide references
to adequate psychometrical testing of the SF-36, Giessener Symptom Checklist (GBB-24) and Daily
Fatigue Impact Scale (D-FIS), none of the Italian studies provide clear reference to adequate testing.
In fact, in two of the latter studies one of the instruments seem to have been labeled differently
while referring to the same reference by Wessely et al. [15]. While Siniscalchi et al. [11] use the label
Chronic Fatigue Syndrome (CFS) questionnaire, Ciacci et al. [13] use the label Verbal Scale for Asthenia.
Moreover, when investigating the original study by Wessely et al. [15] in depth, it seems like this
instrument was developed for this particular study and that the necessary tests for validity and
reliability were not performed, and at least not published.
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3.4. Prevalence of Fatigue and Its Associations
None of the reviewed studies present prevalence data, even though one of the aims in the study
by Siniscalchi et al. [11] were to evaluate the prevalence of fatigue in celiac disease. When looking at
fatigue in patients on normal versus gluten-free diet, results also differ. While Zingone et al. [14] and
Siniscalchi et al. [11] found no significant differences, Jordá et al. [12] found that untreated patients
reported significantly worse fatigue. In addition, when comparing celiac disease patients and healthy
controls, both Häuser et al. [10] and Zingone et al. [14] found impaired scores in celiac disease.
While Zingone et al. [14] found impaired sleep to be associated with increased fatigue,
Jordá et al. [12] found that increased fatigue was associated with impaired HRQoL. Merely two
studies [11,12] investigated potential socio-demographic and clinical factors associated with fatigue,
finding that there is no association between fatigue and factors such as gender, age, or GI symptoms
in celiac disease. While Jordá et al. [12] reported that lower haemoglobin levels were correlated with
worse scores of the D-FIS fatigue scale, Siniscalchi et al. [11] were not able to identify any association.
3.5. Interventions to Alleviate Fatigue
Only one of the studies were designed as an intervention. The study by Ciacci et al. [13] aimed
to investigate the effect on fatigue of a long L-Carnitine treatment in adult celiac disease patients.
While there were no reports of serious adverse events, abdominal and skin problems were registered
in a total of six patients (10%). Moreover, a large number of patients did not complete the study
(n = 13), of which three were dropouts. The main finding is that fatigue scores were significantly
more improved in the intervention versus placebo group. However, even though fatigue scores in the
intervention group displayed a larger decrease than in the placebo group, patients in the intervention
group had a higher fatigue scores than the placebo group at baseline (T0). Moreover, the mean fatigue
VAS at the end of study (T2) was 2.40 (SD 1.80) versus 2.93 (SD 1.85) in the intervention versus placebo
group, respectively. While Ciacci et al. does not report any measures of effect size, calculation of
Cohens d [16] on the differences between the intervention and placebo group at T2 reveal a small effect
size (0.29).
4. Discussion
In this review we were only able to identify 16 papers that, to some extent, had investigated
fatigue in celiac disease. Of these, 11 papers [6,17–26] did not report any specific methodology
concerning fatigue assessment. Of the remaining five papers [10–14], in which fatigue assessment had
been described methodologically, merely three investigated fatigue as the primary endpoint [11–13].
In addition, critical assessment revealed that none of the included studies held high scientific quality.
A basic problem in fatigue research is the lack of a common accepted definition [27]. Indeed,
lack of definition and conceptual clarification was also observed in this review, where only two studies
provided a definition of fatigue [11,13]. On the other hand, the fatigue definitions presented in those
two papers both lacked a clear reference to existing literature.
Fatigue is frequently reported by patients as well as observed by clinicians in celiac
disease [23,25,26]. However, a vast majority of the published literature base their reports merely on
clinical consultation rather than rigorous methodological research (i.e., using validated measurement
tools). Thus, the actual prevalence of fatigue in celiac disease remains unclear. However, there are
indications that the level of fatigue is higher in these patients than in control groups and the background
population [10,14]
We were only able to identify one single study that reported on potential socio-demographic
and clinical factors associated with fatigue symptoms in celiac disease [11]. Of the factors studied,
none were significantly associated with fatigue. However, since data is not shown, it is unclear whether
this finding was true for all of the different fatigue measures used in the study. Furthermore, two of the
included studies found that fatigue was associated with reduced HRQoL and increased sleep problems,
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respectively [12,14]. Although there is currently very limited documentation on these associations,
this appears to coincide with findings in other patient populations [28–32]. In addition, our review
only found one study that was designed as an intervention with fatigue as the primary endpoint.
Even though Ciacci et al. [13] conclude that L-Carnitine therapy is safe and effective in ameliorating
fatigue in celiac disease, these results should be interpreted with extreme caution. Firstly, the study is
hampered by the fact that it does not reach its own power estimates due to a large number of patients
not completing the study (21.6%). Secondly, the study does not use fatigue measurement tools that has
been adequately tested for validity and reliability. In addition, the absolute difference in mean fatigue
VAS between the groups at end of study revealed a small effect size according to Cohen’s d [16,33].
Several studies in other populations have shown that anaemia is associated with increased fatigue
symptoms [7,34]. The pathogenesis of anaemia-related fatigue remains unclear, but some suggest that
abnormalities in energy metabolism play a role in inducing fatigue [35]. Moreover, while some
studies have shown that haemoglobin response is associated with meaningful improvements
in fatigue, others have not been able to reveal any significant association between the use of
erythropoiesis-stimulating agents and fatigue symptom [36,37]. In the current review we were unable
to identify studies that specifically looked at anaemia as predictor of fatigue in celiac disease. However,
Siniscalchi et al. [11] noted that the included celiac patients in their study had significantly lower
haemoglobin levels. A similar observation was reported in Jordá et al. [12]. In the latter study,
a significant correlation between worse fatigue scores and lower haemoglobin levels was reported.
However, even though Jordá et al. [12] report that their regression analysis show that haemoglobin
levels may be involved in the perception of fatigue, the data presented in the paper does not justify
such a conclusion. In fact, the dependent variable used in their study was not fatigue, but HRQoL
(EQ-5D-VAS). Consequently, the current observation on the potential association between fatigue and
anaemia was based on a univariate analysis only.
This review is not without limitations. The fact that we chose to limit our focus to adults and
English publications only may have influenced our identification of relevant publications. On the other
hand, a strength is the rigorous literature search in several databases, as well as the blinded quality
assessment of each of the papers by two of the authors.
5. Conclusions
Although frequently reported in clinical practice, fatigue has been scarcely studied in celiac
disease. In addition, existing literature is characterized by significant methodological weaknesses.
Consequently, there is an unmet need to understand contributing factors for fatigue as well as the
impact of fatigue in celiac disease.
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